Review
Published on 13 Sep 2024
How we diagnose Myelodysplastic syndromes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1415101
- 7,207 views
- 2 citations
Type at least 3 characters
2,008 articles
articles
Review
Published on 10 Sep 2024
Management of infections for patient treated with ibrutinib in clinical practice
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1428464
- 3,620 views
- 1 citation
Case Report
Published on 09 Sep 2024
Case report: Development of clonal hematologic disorders from inherited bone marrow failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1420666
- 1,442 views
Original Research
Published on 05 Sep 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1419118
- 1,918 views
Case Report
Published on 05 Sep 2024
Case report: NUP98::LEDGF fusion gene drives malignant hematological tumor with mixed immunological phenotype
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396655
- 1,593 views
- 2 citations
Case Report
Published on 04 Sep 2024
Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1460557
- 2,171 views
- 2 citations
Case Report
Published on 30 Aug 2024
Liver fibrosis among infants with t(1;22)(p13;q13) acute megakaryoblastic leukemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1441318
- 1,959 views
- 3 citations
Review
Published on 30 Aug 2024
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446723
- 3,788 views
Systematic Review
Published on 30 Aug 2024
Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1403967
- 4,330 views
- 1 citation
Review
Published on 26 Aug 2024
Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1405467
- 3,219 views
- 2 citations
Original Research
Published on 21 Aug 2024
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1387181
- 2,125 views
- 1 citation
Editorial
Published on 19 Aug 2024
Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472463
- 1,558 views
Case Report
Published on 19 Aug 2024
Case report: A case of effective treatment of primary myelofibrosis with nodular panniculitis using ruxolitinib combined with corticosteroids
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1412021
- 2,434 views
Mini Review
Published on 15 Aug 2024
Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1397186
- 2,648 views
- 3 citations
Mini Review
Published on 08 Aug 2024
Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1455464
- 6,190 views
- 4 citations
Original Research
Published on 07 Aug 2024
Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1433821
- 1,830 views
- 1 citation
Case Report
Published on 05 Aug 2024
Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1419145
- 2,226 views
- 4 citations
Review
Published on 02 Aug 2024
MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1410656
- 2,893 views
- 2 citations
Case Report
Published on 01 Aug 2024
Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1417380
- 2,426 views
Case Report
Published on 31 Jul 2024
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1457832
- 2,633 views
Systematic Review
Published on 31 Jul 2024
Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1362367
- 2,334 views
Systematic Review
Published on 31 Jul 2024
Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1341631
- 2,722 views
- 2 citations
Review
Published on 29 Jul 2024
Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446517
- 4,397 views
- 2 citations
Original Research
Published on 29 Jul 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407003
- 5,459 views
- 5 citations